Reports of the start of mass production of immersion DUV lithography machines in China caused short-term panic in the market, but experts urge not to rush to conclusions. ASML shares fell more than 8% during intraday trading, yet the fundamental positions of the Dutch giant remain unshaken.
Information Wave and Its Consequences
The emerging data indicates that the state-owned company Shanghai Aishengna Electronic Technology Group, together with leading Chinese startups, has launched production of immersion DUV systems. It is planned that about 5 units will be produced in 2026, and another 20 in 2027. The first recipients, it is claimed, will be SMIC, Hua Hong Semiconductor, and ChangXin Memory Technologies. However, the key question is not the number of machines, but their stability.
Reality vs. Ambitions
Analysts are unanimous: even if the first deliveries take place, this does not mean readiness for round-the-clock commercial operation. The main barrier is achieving reliable 24/7 system operation over the course of a year. Previous claims about China's progress in lithography have repeatedly turned out to be exaggerated. Moreover, relying on state-owned companies rather than private businesses slows down development, as giants like SMIC and CXMT remain entirely dependent on imported ASML equipment and are interested in its maintenance.
"China will undoubtedly continue to purchase ASML equipment as long as it is possible, due to its significantly superior quality."
The most serious threat to ASML is not Chinese developments, but potential US export restrictions, particularly the Match Act bill. If it forces ASML to withdraw its engineers from China, this could give a powerful boost to local developments. However, even in this case, according to experts, Beijing will not be able to create a single competitor comparable to ASML.
My analysis: The market overreacted to the news, mistaking wishful thinking for reality. China is indeed making progress, but reaching ASML's level requires decades and enormous investments. As long as the Dutch company controls the supply chain and quality, any claims of a "breakthrough" are nothing more than information noise. Investors should focus on real risks—geopolitics and regulatory restrictions—rather than on isolated production successes.